Skip to content
lifestyle.successxl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alvotech
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
June 8, 2026
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
June 4, 2026
Main Results of 2026 Annual and Extraordinary General Meeting
June 3, 2026
Alvotech to present at upcoming investor conferences in June
June 2, 2026
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
May 11, 2026
Alvotech Q1 2026 Financial Results
May 6, 2026
Alvotech Announces a Change in its Executive Team
April 30, 2026
Alvotech to Report Financial Results for the First Quarter of 2026
April 28, 2026
Alvotech Files Annual Report with the SEC
March 30, 2026
Alvotech Q4 2025 and Full Year 2025 Financial Results
March 18, 2026
1
2
Next Page
→